BMPR2 and pulmonary arterial hypertension: Meanwhile, the prevalence of disease‐associated variants in patients with heritable PAH is 70%–87%, with mutations of genes in the bone morphogenetic protein receptor type 2 (BMPR2)/transforming growth factor‐β pathway predominating.9